United Kingdom · Question · Written question
HL HL2601
Tixagevimab/cilgavimab
Introduced
13 October 2022
Last action
—
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 October 2022
Summary
To ask His Majesty's Government, further to the letter from the then Secretary of State for Health and Social Care on 6 September to Gemma Peters, Chief Executive of Blood Cancer UK, which states that “proceeding to patient access [to Evusheld is] conside
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.